Pakistan Pharmaceuticals & Healthcare Report Q2 2015
Pakistan's epidemiological profile will undergo a transition as the burden of non-communicable diseases rises and communicable diseases decline. However, despite the clear need for medical care, poor medical infrastructure, low per capita pharmaceutical spending and high levels of counterfeit medicines prevent the market from realising its full potential.
This report does not have a Table of Contents available
This report does not have a list of Companies Mentioned available
This report does not have a press release associated with it